Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for Adult Hepatic Hemangioma
NCT03633747Phase 2Terminated
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jul 2018
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of propranolol in hepatic hemangioma, sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Started Jul 2018; status: terminated.
02
Drugs
propranolol
03
Conditions
hepatic hemangioma
Beyond the preview
Go deeper on NCT03633747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03633747.